The evolution of antithrombotic treatments in myocardial infarction.
D000925:Anticoagulants / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010447:Peptide Hydrolases / Q000627:therapeutic use; D010973:Platelet Adhesiveness / Q000187:drug effects; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010447:Peptide Hydrolases